Investigators identified a subgroup of older men, however, who may benefit from continued prostate cancer screening. Investigators suggest when older men can consider discontinuing screening while reducing their risk for prostate cancer death.
Investigators identified a subgroup of older men, however, who may benefit from continued prostate cancer screening. Investigators suggest when older men can consider discontinuing screening while reducing their risk for prostate cancer death.
Latest findings are from one of the largest experiences of neoadjuvant chemotherapy in upper tract urothelial carcinoma to date. Study findings are from one of the largest experiences of neoadjuvant chemotherapy in upper tract urothelial carcinoma (UTUC).
Antibiograms help guide the selection of the best empiric antimicrobial treatment when microbiology culture and susceptibility results are pending. Changing diversion approach and incorporating antibiograms may help curb infections after radical cystectomy for bladder cancer.
Investigators report their early clinical experience using intravesical sequential gemcitabine-docetaxel as first-line therapy for high-risk nonmuscle-invasive bladder cancer. Intravesical sequential gemcitabine-docetaxel may be a feasible alternative to BCG for high-risk nonmuscle-invasive bladder cancer (NMIBC).